Effects of acute modafinil ingestion on exercise time to exhaustion

Medicine and Science in Sports and Exercise

Volumn 36, Issue 6, 2004, Pages 1078-1082

  Jacobs, Ira ^a   Bell, Douglas G ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Drugs; Ergogenic AIDS; Narcolepsy; Perceived exertion; Physical performance

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; AEROBIC METABOLISM; ARTICLE; BICYCLE ERGOMETER; CONTROLLED STUDY; DRUG EFFECT; EXERCISE; EXHAUSTION; FATIGUE; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INGESTION; MALE; MOTOR PERFORMANCE; NARCOLEPSY; NORMAL HUMAN; OXYGEN CONSUMPTION; PERCEPTION; SENSATION; TIME;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; EXERCISE; EXERTION; HUMANS; MALE; ONTARIO;

EID: 2642544948     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000128146.12004.4F     Document Type: Article

References (39)

1. AOYAGI, Y., T. M. MCLELLAN, and R. J. SHEPHARD. Effects of 6 versus 12 days of heat acclimation on heat tolerance in lightly exercising men wearing protective clothing. Eur. J. Appl. Physiol. Occup. Physiol. 71:187-196, 1995.
2. BARANSKI, J. V., C. CIAN, and D. ESQUIVIE, Modafinil during 64 hr of sleep deprivation: effects on fatigue, alertness and cognitive performance. Mil. Psychol. 10:173-193, 1998.
3. BARANSKI, J. V., and R. A. PIGEAU. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, damphetamine and placebo. J. Sleep Res. 6:84-91, 1997.
4. BATEJAT, D. M., and D. P. LAGARDE. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat. Space Environ. Med. 70:493-498, 1999.
5. BELL, D. G., I. JACOBS, and J. ZAMECNIK. Effects of caffeine, ephedrine and their combination on time to exhaustion during high-intensity exercise. Eur. J. Appl. Physiol. Occup. Physiol. 77:427-433, 1998.
6. BELL, D. G., and T. M. MCLELLAN. Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. J. Appl. Physiol. 93:1227-1234, 2002.
7. BELL, D. G., and T. M. MCLELLAN. Effect of repeated caffeine ingestion on repeated exercise endurance. Med. Sci. Sports Exerc. 35:1348-1354, 2003.
8. BOIVIN, D. B., J. MONTPLAISIR, D. PETIT, et al. Effects of modafinil on symptomatology of human narcolepsy. Clin. Neuropharmacol. 16:46-53, 1993.
9. BORG, G. A. V. Psychological bases of perceived exertion. Med. Sci. Sports Exerc. 14:377-381, 1982.
10. BRUN, J., G. CHAMBA, Y. KHALFALLAH, et al. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J. Sleep Res. 7:105-114, 1998.
11. BUGUET, A., A. MONTMAYEUR, R. PIGEAU, and P. NAITOH. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep. J. Sleep Res. 4:229-241, 1995.
12. CALDWELL, J. A., JR., J. L. CALDWELL, N. K. SMYTHE, 3RD, and K. K. HALL. A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl.) 150:272-282, 2000.
13. CHANDLER, J. V., and S. N. BLAIR. The effect of amphetamines on selected physiological components related to athletic success. Med. Sci. Sports Exerc. 12:65-69, 1980.
14. CHEUNG, S. S., and T. M. MCLELLAN. Heat acclimation, aerobic fitness, and hydration effects on tolerance during uncompensable heat stress. J. Appl. Physiol. 84:1731-1739, 1998.
15. COSTILL, D. L., G. P. DALSKY, and W. J. FINK. Effects of caffeine ingestion on metabolism and exercise performance. Med. Sci. Sports. 10:155-158, 1978.
16. DUTEIL, J., F. A. RAMBERT, J. PESSONNIER, et al. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol. 180:49-58, 1990.
17. FERRARO, L., T. ANTONELLI, W. T. O'CONNOR, et al. Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol. Psychiatry 42:1181-1183, 1997.
18. FERRARO, L., S. TANGANELLI, W. T. O'CONNOR, et al. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci. Lett. 220:5-8, 1996.
19. FERRARO, L., S. TANGANELLI, W. T. O'CONNOR, et al. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 306:33-39, 1996.
20. FREDHOLM, B. B., K. BATTIG, J. HOLMEN, et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51:83-133, 1999.
21. GAGNON, J., J. M. ROTH, W. F. FINZER, and R. HOFMANN. Superanova: Accessible General Linear Modeling. Berkeley, CA: Abacus Concepts Inc., 1989, pp. 175-216.
22. GILBERT, C. Optimal physical performance in athletes: key roles of dopamine in a specific neurotransmitter/hormonal mechanism. Mech. Age. Dev. 84:83-102, 1995.
23. GREER, F., D. FRIARS, T. E. GRAHAM. Comparison of caffeine and theophylline ingestion: exercise metabolism and endurance. J. Appl. Physiol. 89:1837-1844, 2000.
24. KAMIMORI, G. H., C. S. KARYEKAR, R. OTTERSTETTER, et al. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. J. Pharm. 234:159-167, 2002.
25. KAMIMORI, G. H., D. H. PENETAR, D. B. HEADLEY, et al. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur. J. Clin. Pharmacol. 56:537-544, 2000.
26. LIEBERMAN, H. R., W. J. THARION, B. SHUKITT-HALE, et al. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U. S. Navy SEAL training. Psychopharmacology (Berl.) 164:250-261, 2002.
27. LIGUORI, A., J. R. HUGHES, and J. A. GRASS. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol. Biochem. Behav. 58:721-726, 1997.
28. LIN, J. S., D. GERVASONI, Y. HOU, et al. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. J. Sleep Res. 9:89-96, 2000.
29. LOVINGOOD, B. W., C. S. BLYTH, W. H. PEACOCK, and R. B. LINDSAY. Effects of d-amphetamine sulfate, caffeine, and high temperature on human performance. Res. Q. 38:64-71, 1967.
30. LYONS, T. J., and J. FRENCH. Modafinil: the unique properties of a new stimulant. Aviat. Space Environ. Med. 62:432-435, 1991.
31. MATTAY, V. S., K. F. BERMAN, J. L. OSTREM, et al. Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J. Neurosci. 16:4816-4822, 1996.
32. MCLELLAN, T. M., M. B. DUCHARME, F. CANINI, et al. Effect of modafinil on core temperature during sustained wakefulness and exercise in a warm environment. Aviat. Space Environ. Med. 73:1079-1088, 2002.
33. MOACHON, G., I. KANMACHER, M. CLENET, and D. MATINIER. Pharmokinetic profile of modafinil. Drugs of Today 32(Suppl. 1):23-33, 1996.
34. PASMAN, W. J., M. A. VAN BAAK, A. E. JEUKENDRUP, and A. DE HAAN. The effect of different dosages of caffeine on endurance performance time. Int. J. Sports Med. 16:225-230, 1995.
35. PIGEAU, R., P. NAITOH, A. BUGUET, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J. Sleep Res. 4:212-228, 1995.
36. SMITH, G. M., and H. K. BEECHER. Amphetamine sulphate and athletic performance. JAMA 170:542-557, 1959.
37. SMITH, G. M., and H. K. BEECHER. Amphetamine, secobarbital and athletic performance. JAMA 172:1623-1629, 1960.
38. TURNER, D. C., T. W. ROBBINS, L. CLARK, et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl.) 165:260-269, 2003.
39. WESENSTEN, N. J., G. BELENKY, M. A. KAUTZ, et al. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl.) 159:238-247, 2002.